Abstract:Minocycline (Mino) reduces reperfusion injury and inflammation after stroke in animals and humans, but the late effects on remodeling of the neurovascular unit are less well studied. Previously, we showed that tight junction proteins (TJPs) disappeared from microvessels after reperfusion injury, reappearing in newly formed vessels in peri-infarct regions (peri-I) at 3 weeks, and that MMPs are involved in BBB restoration during recovery. Prior studies of Mino investigated short-term neuroprotective effects with or without tPA. We hypothesized that early treatment with Mino would improve neurovascular remodeling during recovery. To test the hypothesis, we monitored the time course of neurovascular remodeling after spontaneous and Mino-induced stroke recovery. Adult spontaneously hypertensive rats had a 90 min transient MCAO with reperfusion. At the onset of reperfusion they received a single dose of Mino (3 mg/kg, i.v.) or vehicle. They were studied at multiple times up to 4 weeks with MRI, immunohistochemistry, and biochemistry. A single dose of Mino significantly reduced the infarct size and tissue loss in the ischemic hemispheres compared to vehicle-treated rats from 2 to 4 weeks as measured with anatomical T2 MRI and ADC. FA measured at 4 weeks showed improved white matter recovery. ASL showed that Mino improved cerebral blood flow in peri-I by 7 days after reperfusion. BBB permeability in peri-I was reduced with Mino at 4 weeks using dynamic contrast-enhanced MRI. By 4 weeks, Mino induced higher levels of TJPs (occludin, ZO-1, and claudin-5), and MMP-3. We found that active microglia/macrophages, surrounding and within the peri-I, expressed both pro-inflammatory factors (TNF-α and IL-1β) and anti-inflammatory factors (TGF-β and IL-10) at 4 weeks. Western blot analysis showed that treatment with Mino significantly reduced levels of TNF-α and IL-1β, and increased levels of TGF-β and IL-10. Our results suggest that the early treatment with Mino significantly promotes later neurovascular remodeling during stroke recovery by: 1) reducing brain tissue loss; 2) enhancing TJP formation in newly formed vessels; and 3) accelerating functional alteration of microglia activation from pro-inflammatory stage to anti-inflammatory stage.

Early Treatment of Minocycline Alleviates White Matter and Cognitive Impairments after Chronic Cerebral Hypoperfusion

Minocycline Attenuates Brain Edema, Brain Atrophy and Neurological Deficits after Intracerebral Hemorrhage.

The Minocycline Ameliorated the Synaptic Plasticity Impairment in Vascular Dementia

Xi-Xian-Tong-Shuan Capsule Alleviates Vascular Cognitive Impairment in Chronic Cerebral Hypoperfusion Rats by Promoting White Matter Repair, Reducing Neuronal Loss, and Inhibiting the Expression of Pro-Inflammatory Factors.

Minocycline Ameliorates Depressive-Like Behavior and Demyelination Induced by Transient Global Cerebral Ischemia by Inhibiting Microglial Activation

Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP

The effects of minocycline on spatial learning and memory ability and expression of BACE-1 and Aβ in hippocampaus in a rats with chronic cerebral hypoperfusion

Neuroprotection effect of minocycline on early brain injury after subarachnoid hemorrhage in rats

Brain‐selective Mild Hypothermia Promotes Long‐term White Matter Integrity after Ischemic Stroke in Mice

Abstract W MP42: Early Treatment with Minocycline Promotes Neurovascular Remodeling of Tight Junctions Facilitating Recovery after Stroke in Rat Brain

Interleukin-1β Impedes Oligodendrocyte Progenitor Cell Recruitment and White Matter Repair Following Chronic Cerebral Hypoperfusion.

Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury after Subarachnoid Hemorrhage

Chronic Treatment With Minocycline Preserves Adult New Neurons And Reduces Functional Impairment After Focal Cerebral Ischemia

Minocycline alleviates microglia ferroptosis by inhibiting HO-1 during cerebral ischemia-reperfusion injury

Quercetin Alleviates Demyelination Through Regulating Microglial Phenotype Transformation to Mitigate Neuropsychiatric Symptoms in Mice with Vascular Dementia

Theta-burst transcranial magnetic stimulation attenuates chronic ischemic demyelination and vascular cognitive impairment in mice

MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental medicine trial

Attenuation of Acute Stroke Injury in Rat Brain by Minocycline Promotes Blood–brain Barrier Remodeling and Alternative Microglia/macrophage Activation During Recovery

Effectiveness of Minocycline in Acute White Matter Injury after Intracerebral Hemorrhage

Minocycline ameliorates hypoxia-induced blood-brain barrier damage by inhibition of HIF-1α through SIRT-3/PHD-2 degradation pathway

Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor